Development, validation and registration of the HeberFast Line® anti-transglutaminase system. Contribution to the diagnosis of Celiac Disease in Cuba;Desarrollo, validación y registro del sistema HeberFast Line® antitransglutaminasa. Contribución al diagnóstico de la enfermedad celiaca en Cuba

Biotecnologia Aplicada

Volumn 25, Issue 1, 2008, Pages 62-69

  Galván, José A ^a   Acevedo, Boris ^a   Novoa, Lidia I ^a   Palenzuela, Daniel O ^a   Rubí, Julio A ^b   Torres, Edel ^b   Leal, Vladimir ^b   Castellanos, Maylin ^b   Talavera, Carmen ^b   Blanco, Reinaldo ^b   Muño, Milvia ^b   Benítez, Liudmila ^b   Machín, Yeleine ^b   López, Bárbara ^b   Roche, Delia ^b   Díaz, Tamara ^a   Rodríguez, Arlene ^a   Cintado, Alberto ^a   Marchena, Luis ^b   López, Ernesto ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Centro de Ingeniería Genética Y Biotecnología de Sancti Spiritus   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; CUBA; DIAGNOSTIC KIT; DOWN SYNDROME; FEMALE; GIARDIASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE;

EID: 57149086862     PISSN: 08644551     EISSN: 10272852     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sorell L, Galván JA, Acevedo B. Screening of celiac disease in Cuba. In: Catassi C, Fasano A, Corazza GR (eds): The Global Village of Coeliac Disease. Perspectives on Coeliac Disease, vol. II. AIC Press 2005. p.131-5.
2. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk groups in the United States: a large multi-center study. Arch Intern Med 2003;163: 286-92.
3. Cranney AB, Zarkadas M, Graham ID, Switzer CM. The Canadian celiac health survey- The Ottawa chapter pilot. BMC Gastroenterol 2003;3:1-11.
4. Gandolfi L, Pratesi R, Cordova JC, Tauil PL, Gasparin M, Catassi C. Prevalence of celiac disease among blood donors in Brasil. Am J Gastroenterol 2000;95: 689-92.
5. Gómez JC, Selvaggio GS, Viola M, Pizarro B, la Mota G, de Barrio S, et al. Prevalence of celiac disease in Argentina: screening of an adult population in the La Plata area. Am J Gastroenterol 2001;96: 2700-4
6. Sorell L, Garrote JA, Acevedo B, Arranz E. One-step immunochromatographic assay for screening of coeliac disease. Lancet 2002;359(9310):945-6.
7. Sorell L, Garrote JA, Galván JA, Velazco C, Edrosa CR, Arranz E. Celiac Disease Diagnosis in Patients with Giardiasis: High Value of Antitransglutaminase Antibodies. Am J Gastroenterol 2004;99(7):1330-2.
8. Rabasa B, Sagaro E, Fragoso T, Castañeda C, Gra B. Demonstration of celiac disease in Cuba. Bol Med Hosp Infant Mex 1980;37:587-97
9. Rabassa E, Sagaro E, Fragoso T, Castañeda C, Gra B. Coeliac disease in Cuban children. Arch Dis Child 1981;56: 128-31.
10. Sagaro E, Jimenez N. Family studies of celiac disease in Cuba. Arch Dis Child 1981;56:132-3.
11. Cintado A, Sorell L, Galván JA, Martínez L, Castañeda C, Fragoso T, et al. LI1HLA DQA1*0501 and DQB1*02 in Cuban celiac patients. Hum Immunol 2006;67(8):639-42.
12. Sánchez JC, Cabrera-Rode E, Sorell L, Galván JA, Hernández A, Molina G, et al. Celiac disease associated antibodies in persons with latent autoimmune diabetes of adult and type 2 diabetes. Autoimmunity 2007;40(2):103-7.
13. Castaneda C, Alvarez-Fumero R, Sorell L, Galván JA, Carvajal F. Screening for celiac disease in risk groups in Cuba. Journal of Pediatric Gastroenterology and Nutrition (Supplement June). 2004;39:S211-2.
14. Galván JA, Cabrera-Rode E, Molina G, Díaz-Horta O, Palenzuela DO, Novoa LI, et al. Celiac disease-associated antibodies in type 1 diabetes patients in Cuba. Biotecnol Apl 2008;25:47-50.